Regulatory agencies in Argentina and Brazil on the specific characteristics for clinical...

Regulatory agencies in Argentina and Brazil on the specific characteristics for clinical trial development in each country – Latin America Clinical Trials Conference – ExL Pharma



SHARE THIS ARTICLE

New York, NY–(HISPANIC PR WIRE – BUSINESS WIRE)–February 27, 2008–ExL Pharma
(http://www.exlpharma.com) proudly announces the Inaugural Latin America Clinical Trials Conference, the only clinical trial event dedicated to running clinical trials in Latin America, March 10-11, 2008 at the Hyatt Regency in Miami, Florida. For full details, go to:
http://www.exlpharma.com/eventDetail.php?id=102. When registering, provide registration and priority code: P704PR.

The pre-conference workshop will be lead by Luis Meza, Managing Director of Latin America Operations at RPS, INC., who will feature industry perspectives on establishing beneficial partnerships with service providers in Latin America to maximize trial performance. The main conference will feature Analia Perez, the Director of Drug Evaluation from ANMAT ARGENTINA and Dr. Granville Garcia de Oliveira, the Clinical Trials and New Drugs Office Manager from the NATIONAL HEALTH SURVEILLANCE AGENCY (ANVISA), BRAZIL. They will be presenting on specific regulatory characteristics in their countries and the Latin American Region. Also featured will be presentations from pharmaceutical industry leaders Pfizer, Roche, and Bristol-Myers Squibb on various clinical trial issues such as good clinical practice, patient recruitment and retention, investigator relationships and strategies for long-term trial success within the Latin American region.

For event details, the most up-to-date agenda and to register, go to: http://www.exlpharma.com/eventDetail.php?id=102. When registering, provide registration and priority code: P704PR.

About ExL Events – http://www.exlpharma.com

ExL Pharma, a division of ExL Events, Inc., is an emerging international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.

Regulatory agencies in Argentina and Brazil on the specific characteristics for clinical trial development in each country – Latin America Clinical Trials Conference – ExL Pharma